's () CEO Malcolm Pye and CFO Mark Plampin discuss with Proactive London's Andrew Scott the aquaculture group's results for the year to September 2018.
Pye says demand for disease and sea lice resistant salmon eggs has already meant a good start to trade in 2019.
In 2018, revenues rose by 13% to £151.5mln while underlying profits jumped by 68% to £17mln as gross margins rose four percentage points.
Meet Faron Pharmaceuticals Ltd, Belvoir Lettings, Silence Therapeutics PLC, ANGLE PLC and ReNeuron Group PLC at our event,
London , 23 May 2019.
Register here »